Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Posts Revenue Surge in Q4; Net Loss Widens Slightly

NEW YORK, Feb. 19 - Gene Logic on Tuesday posted swelling revenue and a  slightly widened net loss in the fourth quarter.


For the period ended Dec. 31, total revenue jumped 49 percent to $14 million from $9 million one year ago, the company said. The increase was attributed to new customers for its GeneExpress product line and expanded existing subscriptions.


Gene Logic also posted a slight increase in R&D, to $14 million in the current fourth quarter from $13 million in the year-ago period.


Fourth quarter net loss widened moderately to $6.0 million, or $.22 per share, from $5.4 million, or $.21 per share, year over year. Gene Logic said that falling interest rates in the quarter caused a decline of $2.4 million, or $.09 per share, contributed to the net loss.


Gene Logic, of Gaithersburg, Md., said it had close to $200 million in cash and cash equivalents as of Dec. 31.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.